This HTML5 document contains 183 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n12http://dx.doi.org/10.1136/
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35554739
rdf:type
wikibase:Item
schema:description
vitskapeleg artikkel наукова стаття, опублікована в липні 2004 artikulong pang-agham artikel ilmiah מאמר מדעי mokslinis straipsnis 2004年论文 ৮ জুলাই ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico научни чланак 2004年論文 vitenskapelig artikkel tieteellinen artikkeli 2004년 논문 scientific article published on 8 July 2004 научна статия 2004 nî lūn-bûn artigo científico artículo científico publicado en 2004 wetenschappelijk artikel articolo scientifico article científic 2004年论文 article scientifique scientific article published on 8 July 2004 tudományos cikk 2004年論文 գիտական հոդված bài báo khoa học 2004年论文 2004年論文 vetenskaplig artikel научни чланак artikull shkencor naučni članak мақолаи илмӣ article scientific vědecký článek บทความทางวิทยาศาสตร์ articol științific 2004年论文 vedecký článok научная статья artigo científico 2004年の論文 bilimsel makale artículu científicu espublizáu en 2004 wissenschaftlicher Artikel мақолаи илмӣ 2004年论文 teaduslik artikkel scientific article published on 8 July 2004 2004年論文 επιστημονικό άρθρο scienca artikolo artykuł naukowy სამეცნიერო სტატია 2004年论文 مقالة علمية نشرت في 8 يوليو 2004 2004年論文 videnskabelig artikel
p:P577
wds:Q35554739-96372052-FC59-4B6E-9333-A2485341D60A
wdt:P577
2004-07-08T00:00:00Z
p:P407
wds:Q35554739-4821ECB3-E7A2-4280-BB44-FC1930BCB4F3
wdt:P407
wd:Q1860
p:P2860
wds:Q35554739-07CB94C0-6BC4-4095-A497-6D4F6696F9E3 wds:Q35554739-2115CBE6-E09C-4A29-AA8E-4ECA20938C9B wds:Q35554739-23301B5F-5DA3-49B8-B26E-E5188EDD3B3A wds:Q35554739-2384EB0C-E296-46BE-AB43-670B2B1656FE wds:Q35554739-23CDDF08-D092-4B83-841D-7A3D291DD88C wds:Q35554739-2C65444A-8E82-4ABA-B3A6-A2D1F22DAFE8 wds:Q35554739-8C251A66-734B-4114-BE89-5FCC773210D4 wds:Q35554739-8D1D8B92-F5A1-4F12-A268-2BECFF01778D wds:Q35554739-9694A5AC-2878-4153-A1CA-384036773EAB wds:Q35554739-9857D6ED-42B2-4DA3-8BED-C323B24E30DF wds:Q35554739-B098D5B1-6B2D-4E54-9173-2732D4E04F4F wds:Q35554739-B380C657-AABE-4322-9F35-D171AC57E706 wds:Q35554739-C63DEBB1-2708-4419-88FC-303DB0816D09 wds:Q35554739-C8817F81-AEC3-4DA0-A4CA-D78734F3508A wds:Q35554739-541D6E19-BA2F-4DCC-A0B4-1F74937C811F wds:Q35554739-58CD4D47-216E-4972-936C-CECD6B038971 wds:Q35554739-5B7E3E31-09C9-427D-9EED-1FC0586EC26D wds:Q35554739-5D773523-02B4-43B6-BDC9-A94C7DFC61EB wds:Q35554739-601CF0C7-9944-428C-A0F8-19E7340F4F8E wds:Q35554739-6196750D-D7C9-4AE4-999D-FEA361287F27 wds:Q35554739-6F2DE983-1528-4E5F-A5CA-6B4E1B683410 wds:Q35554739-7FA11109-AA9C-485C-9E09-86E9AC944ABE wds:Q35554739-875FA745-6620-4636-861F-3940D7F2D75A wds:Q35554739-D094027F-12CB-4EA6-8676-2F4054810501 wds:Q35554739-E40D0468-B629-4C9C-A2A9-EF3201AF2146 wds:Q35554739-EFBA674F-8667-441C-B3D9-6D6F10A4894B
wdt:P2860
wd:Q52225534 wd:Q74175879 wd:Q52221782 wd:Q53988786 wd:Q72767540 wd:Q73490946 wd:Q39528308 wd:Q40931449 wd:Q78115511 wd:Q33885648 wd:Q44321562 wd:Q50850177 wd:Q77910676 wd:Q27860872 wd:Q73386051 wd:Q73101125 wd:Q45855775 wd:Q24793971 wd:Q71160284 wd:Q73573994 wd:Q41698607 wd:Q35553245 wd:Q41824468 wd:Q71781127 wd:Q57675150 wd:Q24800661
p:P2093
wds:Q35554739-4EEBF26C-6F55-465C-B011-73E1F19629EB wds:Q35554739-70487ECE-FBAE-4AD4-9703-D5C1676EE42D wds:Q35554739-8935126E-BF86-4BEE-A4F3-292E27770296 wds:Q35554739-B79AFB4E-FDAB-43D8-9B0C-B4A06C10E31B wds:Q35554739-BC35F1A3-C7FE-43F6-A1D6-0ADFA2F0AD11 wds:Q35554739-AB643557-51FB-4783-8EAC-80CAFF459977 wds:Q35554739-05046FB1-98F4-4C80-A6FE-FC032FE6725C wds:Q35554739-1B6664A7-7E47-4BD4-9B54-2FF331A789E2 wds:Q35554739-189B05C9-1DEF-4495-A729-B8454619CDC2 wds:Q35554739-4D9F96F1-4023-4FF3-AFC8-1C797A65B619
wdt:P2093
Alvaro J van Holten J Nuki G Genovese M Rozman B Stahl H Kivitz AJ Furst DE Musikic P Tak PP
rdfs:label
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.
skos:prefLabel
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.
schema:name
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.
p:P50
wds:Q35554739-D67693D8-9A3C-4B82-857E-6D1A59B7A4CF wds:Q35554739-77D68A53-A106-4855-B95C-9B14C4FA0B82 wds:Q35554739-5F5DF703-2244-4DA9-85E0-9F985DCE40DA wds:Q35554739-53E499D9-A2C4-4010-B638-906C53F1803D
wdt:P50
wd:Q42186933 wd:Q41687181 wd:Q12028453 wd:Q42956790
p:P1476
wds:Q35554739-B4C55409-19C9-40BE-BB9E-36AF58CA1410
wdt:P1476
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis
p:P304
wds:Q35554739-166F411C-C5AB-4066-AC07-E144EF0EA971
wdt:P304
64-69
p:P31
wds:Q35554739-CD8D3643-2DCD-482F-8855-FF86DAE52C16
wdt:P31
wd:Q13442814
p:P921
wds:Q35554739-0595B0C3-C364-41FD-92A4-10F0379C450A wds:Q35554739-131CE0BE-AB1D-4E25-A692-D81EB16BE92D wds:Q35554739-D03B519E-DF08-4FD6-9E99-5038A2845EE6
wdt:P921
wd:Q269829 wd:Q187255 wd:Q6934595
p:P698
wds:Q35554739-05428904-CA6F-424C-B8FA-F948D8BB63B4
wdtn:P698
n9:15242865
wdt:P698
15242865
p:P1433
wds:Q35554739-6F1313D8-369A-41A6-8048-41734C94EBBC
wdt:P1433
wd:Q4767876
p:P433
wds:Q35554739-6A4F31F0-59EE-45BA-8873-84774DC2C9A4
p:P478
wds:Q35554739-2418DCA8-4034-4A6F-8595-58F612A00C15
wdt:P433
1
wdt:P478
64
p:P356
wds:Q35554739-A65BA823-02B4-4BD0-9E84-2ACB8DCDC2B0
wdtn:P356
n12:ARD.2003.020347
wdt:P356
10.1136/ARD.2003.020347
p:P5875
wds:Q35554739-9F06AA93-597E-4234-9066-9B147DEDDE21
wdt:P5875
8466120
p:P932
wds:Q35554739-2D112847-D022-41BF-B9A1-F2F61259EDD5
wdt:P932
1755211